Category:

Non-Life

Doctor On Call aims for 10 lakh subscribers by 2021-end

Doctor On Call rolled out the Swasthya Sewa initiative in July this year which offers doctor consultation to patients over a call for all kinds of ailments. The subscribers need to pay Rs 500 for a family as annual subscription fee to avail the company’s services. The company follows two models to cater to its subscribers. For complex ailments it has tie-ups with hospitals and specialist doctors and in order to cater to regular health issues of the subscribers, the company has around 15 doctors on its rolls.

read more

Historic U.S. COVID vaccine campaign launches with convoy of trucks

The federal government plans to release the nation’s first 2.9 million doses to 64 states, U.S. territories and major cities, as well as five federal agencies. Although the federal government is coordinating distribution efforts, states have the final decision over who gets the first shots. The federal government is sending the first shipments to more than 600 locations.

Companies in a range of industries are lobbying state and federal officials to give priority to their workers in the line of millions waiting for the vaccine and a return to life free from the fear of the deadly illness.

read more

74.3% passengers refunded ₹3,200 crore for lockdown-induced flight cancellations: Govt

The Supreme Court had on October 1 said that a full and immediate refund should be given to passengers for the air tickets cancelled between March 25 and May 24. No scheduled domestic and international passenger flights operated in the country in this period.

‘Pursuant to Honourable Supreme Court’s order on ticket refund, 74.3% of total 55,23,940 PNRs amounting to Rs 3,200 crore have been refunded. Rest are in process,’ the ministry tweeted.

read more

How pandemic bonds became the world’s most controversial investment

Here’s how the pandemic bonds worked.

The World Bank would sell $320 million of debt to investors. In the event of a pandemic, that debt would be written off and the principal would accrue to the bank to be distributed to needy countries. Premiums were juicy – the safest slice of the offering paid 6.9% over the Libor benchmark rate, similar to returns typically found on junk-rated corporate bonds and far greater than the 2.2% available on 10-year U.S. government debt at the time. For the second tranche, which had looser triggers for a writeoff, premiums were a whopping 11.5%.

read more

India readies for 600 million COVID vaccine jabs; to use standard cold storage – top government expert

“The four that I can see, including Serum, Bharat, Zydus, and Sputnik need normal cold chain. I see no problem for these vaccines,” ,V.K. Paul, who heads the group of experts on vaccine administration, told Reuters in an interview.

Serum Institute of India, the world’s largest vaccine maker, is already mass producing and stockpiling AstraZeneca’s Covishield shot, while Indian biotech players Bharat Biotech and Zydus Cadila are developing their own vaccine candidates.

read more